PAX-2 in the Diagnosis of Primary Renal Tumors Immunohistochemical Comparison With Renal Cell Carcinoma Marker Antigen and Kidney-Specific Cadherin

Creative Commons License

Ozcan A., Zhai J., Hamilton C., Shen S. S., Ro J. Y., Krishnan B., ...Daha Fazla

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, cilt.131, sa.3, ss.393-404, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 131 Sayı: 3
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1309/ajcpm7dw0xfhdhny
  • Dergi Adı: AMERICAN JOURNAL OF CLINICAL PATHOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.393-404
  • Hacettepe Üniversitesi Adresli: Hayır

Özet

The diagnosis of renal cell carcinoma (RCC) remains problematic, especially in the context of metastasis or small needle biopsy specimens. The renal cell carcinoma marker (RCCM) and kidney-specific cadherin (KSC) are considered specific markers for RCC but are expressed preferentially in specific subtypes of RCC of lower grades. This study was aimed at evaluating the usefulness of PAX-2 in the diagnosis of renal tumors and comparing it with that of RCCM and KSC. Immunostaining for PAX-2, RCCM, and KSC was performed on consecutive tissue sections of 130 renal tumors.